Canopy Growth expands European medical cannabis supply into the U.K.
Canopy Growth reached an agreement to supply four Canadian-grown medical flower strains to a cannabis-based medicines maker that will commercialize them under Canopy’s Spectrum Therapeutics brand in the U.K.
Canopy Growth said it has reached an agreement to bring its cannabis products into the U.K. market, supplying four Canadian-grown medical flower strains to a maker of cannabis-based medicines. The partner will commercialize the products under Canopy's Spectrum Therapeutics brand.